Jushi Holdings Refinances $132M Debt to 2029, Reports Mixed Q4/FY25 Results, & Notes Virginia Adult-Use Progress
Summary
Jushi Holdings reported mixed Q4/FY25 results, but significantly strengthened its balance sheet by refinancing $132.3 million in debt to 2029 and noted positive progress on Virginia adult-use cannabis legislation.
Key Events
-
Significant Debt Refinancing Completed
In March 2026, Jushi refinanced approximately $132.3 million of existing senior secured term loan and second lien notes with a new $160.0 million 12.5% secured term loan due in 2029. This transaction extends debt maturities and enhances liquidity, with participation from the CEO and a significant equity holder.
-
Mixed Q4 and Full Year 2025 Financial Results
For Q4 2025, revenue increased 3.8% year-over-year to $68.3 million, and Adjusted EBITDA surged 74.0% to $13.9 million. However, the net loss widened to $15.6 million. For the full year 2025, revenue grew 2.1% to $262.9 million, but net loss increased to $68.6 million, while Adjusted EBITDA improved 8.8% to $50.3 million.
-
Virginia Adult-Use Cannabis Legislation Progress
The Virginia General Assembly passed adult-use cannabis legislation, establishing a regulated retail market with sales projected to begin January 1, 2027, subject to the Governor's approval. This represents a substantial potential market expansion for Jushi, which has existing infrastructure in the state.
Analysis
Jushi Holdings Inc. announced its fourth quarter and full year 2025 financial results, which showed mixed performance with modest revenue growth and a wider net loss, but significant improvement in Q4 Adjusted EBITDA. Crucially, the company also disclosed a major post-quarter-end debt refinancing, extending maturities to 2029 and enhancing liquidity. This refinancing, which saw participation from the CEO and a significant equity holder, addresses a substantial portion of the company's debt relative to its market capitalization. Additionally, the passing of Virginia adult-use cannabis legislation by the General Assembly, pending Governor's approval, presents a significant future growth opportunity for Jushi, which operates in the state. These strategic financial and regulatory developments are highly important for the company's long-term stability and growth prospects.
At the time of this filing, JUSHF was trading at $0.51 on OTC in the Life Sciences sector, with a market capitalization of approximately $99.4M. The 52-week trading range was $0.23 to $0.98. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.